OTC - ACTIVE INGREDIENT SECTION
Active ingredient
chlorhexidine gluconate 2% solution
Povidone-Iodine USP, 5%
Active ingredient
chlorhexidine gluconate 2% solution
Povidone-Iodine USP, 5%
Purpose
Antiseptic
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Uses
Warnings
For external use only
Do not use
When using this product
Do not use if you have a known sensitivity to iodine or any other ingredient in this product. Do not use in eyes. If product gets into eyes, flush immediately with water. Do not use on infants less than 2 months old due to the risk of increased blood iodine levels.
Stop use and ask a doctor if irritation, sensitization or allergic reaction occurs. These may be signs of a serious condition.
Directions
2% Chlorhexidine Gluconate Cloth
To open package
Or
Directions
3M Skin and Nasal Antiseptic
Skin Application:
Nasal Application:
Inactive ingredients
2% Chlorhexidine Gluconate Cloth
aloe vera, dimethicone, fragrance, glucono-delta-lactone, glycerin, Igepal, polysorbate 20, propylene glycol, USP purified water
cloth: polyester
Inactive ingredients
3M Skin and Nasal Antiseptic
Lactic acid, lauramidopropylamine oxide, malic acid, polyquarternium-10, PPG-5-ceteth-10 phosphate, sodium hydroxide, sodium iodide, steareth-100, water, xylitol
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 846127 | chlorhexidine gluconate 2 % Medicated Pad | PSN | 1 |
| 252965 | povidone-iodine 5 % Topical Solution | PSN | 1 |
| 846127 | chlorhexidine gluconate 20 MG/ML Medicated Pad | SCD | 1 |
| 252965 | povidone-iodine 50 MG/ML Topical Solution | SCD | 1 |
| 846127 | chlorhexidine gluconate 2 % Medicated Pad | SY | 1 |
| 252965 | povidone-iodine 5 % (titratable iodine 0.5 % ) Topical Solution | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CHLORHEXIDINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| 5f30b278-5791-4113-8781-878a9221ef8a | Product name | 2 | 20230125 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 2a70c781-a755-4d76-b20a-a958acfbdcdc | Product name | 2 | 20190619 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 304592ef-4a8a-4c22-8e8c-af73aa3d60e5 | Product name | 1 | 20180703 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| ac0821a1-ce75-4ea7-880a-59eecaecdf22 | Product name | 1 | 20180703 |
| db5dc4f9-b907-46f6-8fb7-babcf04bbe5c | Product name | 1 | 20180619 |
| 41e9d6cf-3ed7-4c44-a57e-0685058d0896 | Product name | 1 | 20170824 |
| 5e652c92-68fd-426b-b0e7-5fc64e0b9f99 | Product name | 1 | 20170309 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
| ddc0c11a-bba8-408f-b3c7-c4828b4bcc8c | Product name | 1 | 20150421 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53462-008-28 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-6748-f424-e053-dadaa90a57ce | 2% Chlorhexidine Gluconate Cloth and 3M Skin and Nasal Antiseptic |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17518-060-04 | Skin antisepsis, oral cleansing, nasal antisepsis | 4 mL in 1 BOTTLE | SOLUTION | 4 mL | 5 mg in 1mL | 1 |
| 53462-008-28 | Skin antisepsis, oral cleansing, nasal antisepsis | 1 in 1 KIT | KIT | 1 | 1 | |
| 53462-705-23 | Skin antisepsis, oral cleansing, nasal antisepsis | 6 in 1 PACKAGE | CLOTH | 6 | 500 mg | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17518-060 | SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS, INC.] | 1 | Current NDC, Legacy NDC | 20121026_d36bf0aa-9dec-3328-cab8-8fc6748dafb3.zip |
| 53462-008 | SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS, INC.] | 1 | Legacy NDC, 3 package rows | 20121026_d36bf0aa-9dec-3328-cab8-8fc6748dafb3.zip |
| 53462-705 | SKIN ANTISEPSIS, ORAL CLEANSING, NASAL ANTISEPSIS (CHLORHEXIDINE GLUCONATE) KIT [SAGE PRODUCTS, INC.] | 1 | Current NDC, Legacy NDC | 20121026_d36bf0aa-9dec-3328-cab8-8fc6748dafb3.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17518-060-04 | EA - Each | 17518-060 | 87da09da-00f8-4da0-aca0-5f3802b38dbc | 1 | 2024-04-05 |
| 53462-705-20 | EA - Each | 53462-705 | 07f8a3cf-9379-4359-bae1-02cecd93793c | 1 | 2012-07-24 |
| 53462-705-23 | EA - Each | 53462-705 | 3d90eac6-c72f-4444-b4d0-c4ea1b1b88f0 | 1 | 2012-07-24 |
| 53462-705-26 | EA - Each | 53462-705 | 8ee590b2-e855-4f04-8861-4ed0d0b878fc | 1 | 2024-04-05 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| chlorhexidine gluconate | ACTIVE INGREDIENT | MOR84MUD8E | 1 | |
| POVIDONE-IODINE | ACTIVE INGREDIENT | 85H0HZU99M | 1 | |
| chlorhexidine | ACTIVE MOIETY | R4KO0DY52L | 1 | |
| IODINE | ACTIVE MOIETY | 9679TC07X4 | 1 | |
| aloe vera leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| dimethicone 350 | INACTIVE INGREDIENT | 2Y53S6ATLU | 1 | |
| gluconolactone | INACTIVE INGREDIENT | WQ29KQ9POT | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | 1 | |
| LAURAMIDOPROPYLAMINE OXIDE | INACTIVE INGREDIENT | I6KX160QTV | 1 | |
| MALIC ACID | INACTIVE INGREDIENT | 817L1N4CKP | 1 | |
| nonoxynol-9 | INACTIVE INGREDIENT | 48Q180SH9T | 1 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| SODIUM IODIDE | INACTIVE INGREDIENT | F5WR8N145C | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XYLITOL | INACTIVE INGREDIENT | VCQ006KQ1E | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 53462-008 | 53462-008-28 |
| 17518-060 | 17518-060-04 |
| 53462-705 | 53462-705-23 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| chlorhexidine gluconate | MOR84MUD8E | ACTIB |
| water | 059QF0KO0R | IACT |
| nonoxynol-9 | 48Q180SH9T | IACT |
| polysorbate 20 | 7T1F30V5YH | IACT |
| dimethicone 350 | 2Y53S6ATLU | IACT |
| propylene glycol | 6DC9Q167V3 | IACT |
| aloe vera leaf | ZY81Z83H0X | IACT |
| glycerin | PDC6A3C0OX | IACT |
| gluconolactone | WQ29KQ9POT | IACT |
| POVIDONE-IODINE | 85H0HZU99M | ACTIB |
| LACTIC ACID | 33X04XA5AT | IACT |
| LAURAMIDOPROPYLAMINE OXIDE | I6KX160QTV | IACT |
| MALIC ACID | 817L1N4CKP | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| SODIUM IODIDE | F5WR8N145C | IACT |
| PEG-100 STEARATE | YD01N1999R | IACT |
| WATER | 059QF0KO0R | IACT |
| XYLITOL | VCQ006KQ1E | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CLOTH / TOPICAL | NA | ||
| dimethicone 350 | DIMETHICONE 350 | 2Y53S6ATLU | CLOTH / TOPICAL | NA | ||
| MALIC ACID | MALIC ACID | 817L1N4CKP | SOLUTION / ORAL | 16760 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / TOPICAL | 39 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| MALIC ACID | MALIC ACID | 817L1N4CKP | SOLUTION / ORAL | 16760 mg | ||
| gluconolactone | GLUCONOLACTONE | WQ29KQ9POT | SOLUTION / TOPICAL | 0.3 %w/w | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SOLUTION / TOPICAL | 15 %w/w | ||
| LACTIC ACID | LACTIC ACID | 33X04XA5AT | SOLUTION / TOPICAL | 7.22 %w/w | ||
| dimethicone 350 | DIMETHICONE 350 | 2Y53S6ATLU | SOLUTION / TOPICAL | 0.5 %w/w | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| gluconolactone | GLUCONOLACTONE | WQ29KQ9POT | CLOTH / TOPICAL | NA | ||
| gluconolactone | GLUCONOLACTONE | WQ29KQ9POT | CLOTH / TOPICAL | NA | ||
| nonoxynol-9 | NONOXYNOL-9 | 48Q180SH9T | CLOTH / TOPICAL | NA | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SOLUTION / ORAL | 21600 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CLOTH / TOPICAL | 0.03 mg/mg | ||
| LACTIC ACID | LACTIC ACID | 33X04XA5AT | SOLUTION / TOPICAL | 7.22 %w/w | ||
| SODIUM IODIDE | SODIUM IODIDE | F5WR8N145C | SPONGE / TOPICAL | 0.74 %w/w | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CLOTH / TOPICAL | 0.03 mg/mg | ||
| SODIUM IODIDE | SODIUM IODIDE | F5WR8N145C | SPONGE / TOPICAL | 0.74 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| nonoxynol-9 | NONOXYNOL-9 | 48Q180SH9T | CLOTH / TOPICAL | NA | ||
| gluconolactone | GLUCONOLACTONE | WQ29KQ9POT | SOLUTION / TOPICAL | 0.3 %w/w | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SOLUTION / TOPICAL | 15 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| dimethicone 350 | DIMETHICONE 350 | 2Y53S6ATLU | CLOTH / TOPICAL | NA | ||
| XYLITOL | XYLITOL | VCQ006KQ1E | SOLUTION / ORAL | 21600 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / TOPICAL | 4886 mg | ||
| SODIUM IODIDE | SODIUM IODIDE | F5WR8N145C | SPONGE / TOPICAL | 0.74 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / TOPICAL | 39 mg | ||
| polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CLOTH / TOPICAL | NA | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| dimethicone 350 | DIMETHICONE 350 | 2Y53S6ATLU | SOLUTION / TOPICAL | 0.5 %w/w | ||
| SODIUM IODIDE | SODIUM IODIDE | F5WR8N145C | SPONGE / TOPICAL | 0.74 %w/w |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021669-001 | CHLORHEXIDINE GLUCONATE | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 |
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N021669-001 | 7427574 | 2026-04-25 | Drug product | ||
| N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021669-001 | CHLORHEXIDINE GLUCONATE | 2% | CLOTH / TOPICAL | RLD, RS | 2005-04-25 | f41ea6bd6efb… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021669-001 | 7427574 | 2026-04-25 | Drug product | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N021669-001 | 7427574 | 2026-04-25 | Drug product | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021669-001 | 7427574 | 2026-04-25 | Drug product | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021669-001 | 7427574 | 2026-04-25 | Drug product | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021669-001 | 7427574 | 2026-04-25 | Drug product | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021669-001 | 7427574 | 2026-04-25 | Drug product | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021669-001 | 7427574 | 2026-04-25 | Drug product | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021669-001 | 7066916 | 2024-02-17 | U-737 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021669-001 | 7427574 | 2026-04-25 | Drug product | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021669-001 | 7066916 | 2024-02-17 | U-737 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021669-001 | 7427574 | 2026-04-25 | Drug product | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021669-001 | 7066916 | 2024-02-17 | U-737 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021669-001 | 7427574 | 2026-04-25 | Drug product | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021669-001 | 7066916 | 2024-02-17 | U-737 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021669-001 | 7427574 | 2026-04-25 | Drug product | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021669-001 | 7066916 | 2024-02-17 | U-737 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021669-001 | 7427574 | 2026-04-25 | Drug product | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N021669-001 | 7935093 | 2027-10-02 | U-1022 | Drug product | 2011-05-24 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021669-001 | 7066916 | 2024-02-17 | U-737 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021669-001 | 7717889 | 2025-02-27 | U-1022 | Drug product | 2012-05-25 | 79d66fd596c7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CHLORHEXIDINE GLUCONATE | CHLORHEXIDINE GLUCONATE | Sage Products LLC | bdb6a012-37e5-4664-84a3-134bea284744 | 2026-06-16 | Warnings | 53462-705-23 53462-705 53462070523 |
| 3M Skin and Nasal Antiseptic | POVIDONE-IODINE | Solventum US LLC | 1a94494d-7dd3-4f32-bc42-81c199fe233e | 2026-04-22 | Warnings | 17518-060-04 17518-060 17518006004 |
| d36bf0aa-9dec-3328-cab8-8fc6748dafb3 | d36bf0aa-9dec-3328-cab8-8fc6748dafb3 | 2012-10-22 | Warnings | d36bf0aa-9dec-3328-cab8-8fc6748dafb3 d36bf0aa-9dec-3328-cab8-8fc6748dafb3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.